News
Worldwide, gastric cancer is considered the fifth most frequently diagnosed cancer and the third leading cause of cancer mortality [ 1 ].
Cyklin-abhängige Kinase-4/6-Inhibitoren (CDK4/6i) haben die Behandlung des HR+/HER2− (Hormonrezeptor-positiven, humaner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback